/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Savient Pharmaceuticals Inc\n \n\n\n\n\n
Nov 21 10:31 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 13, 2009 6:53 AM EST
\n\n \n AnalystChoice.com Initiates Research on SSRI, PLCE, SVNT, ARUN, STSI and TQNT - Marketwire\n \n \n
\n\n Nov 04, 2009 7:23 PM EST
\n\n \n Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results - PR Newswire\n \n \n
\n\n Nov 04, 2009 5:30 AM EST
\n\n \n RothmanResearch.com Market Review and Company Analysis on SYNA, ARUN, CELG, SVNT, PRGN and SWHC - Marketwire\n \n \n
\n\n Oct 28, 2009 6:32 PM EDT
\n\n \n Savient Pharmaceuticals to Hold Third Quarter 2009 Financial Results Conference Call on Thursday, November 5, 2009 - PR Newswire\n \n \n
\n\n Oct 27, 2009 4:31 PM EDT
\n\n \n Savient Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference - GlobeNewswire\n \n \n
\n\n Oct 26, 2009 7:10 AM EDT
\n\n \n WallStSense.com Offers Detailed Analysis on DWA, SVNT, ATVI, SSRI, CIEN and AVNR - Marketwire\n \n \n
\n\n Oct 15, 2009 11:22 AM EDT
\n\n \n Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option - PR Newswire\n \n \n
\n
\n\n");